自体CAR-T细胞治疗产品中、美、欧上市后变更管理政策分析
李应梦, 施文瑜, 姚东宁, 张丽颖
Post-Marketing Change Management Policy Analysis of Autologous CAR-T Therapy Products in China, the United States, and the European Union
Li Yingmeng, Shi Wenyu, Yao Dongning, Zhang Liying
中国药事
.
2026, (10): 1200
-1211
.
DOI: 10.16153/j.1002-7777.2025-12-0011
